Beimei Pharma focuses on the field of pediatric prescription medicines, headquartered in Shenzhen, China, National High-tech Enterprise, National Science and Technology-based Small and Medium-sized Enterprises, Shenzhen Specialized, Redefined, Differentiated and Innovative Enterprise, Shenzhen Innovative Small and Medium-sized Enterprise. Beimei pharmaceutical incorporates R&D, global licensing, manufacture, marketing and distribution, and has more than 30 pediatric products in its portfolio and pipeline, covering the respiratory system, anti-infection (antibacterial), nervous system, digestive system, endocrinology, ENT and other fields.
Beimei Pharma has established long-term partnerships with some outstanding international pharmaceutical companies, including LTS, Medpharm, Cipla, NTC, Sythorn, Deva holding, EMP, Syrimed, Hetero, Dr.Reddy’s etc. and completed over 100 million RMB series A , series B/B+ and Series C financing, which will further support Beimei to be a pioneer in Chinese pediatric field to meet the clinically unmet demand and provide Chinese pediatric patients with products that are with high-quality, good tasting and can be accurately administrated.
Shenzhen Beimei Pharmaceutical Co., Ltd. adhering to the business philosophy of "People-oriented, Quality in Priority, Sustainable Innovation and honest service", following the core values of "Courageous to Fight, Earnest and Impartial, Eager for Learning and Sharing, Professional and Efficient". With the goal of becoming the leading enterprise of pediatric medicine in China, we'll make our contributions to the Chinese pediatric industry .
People oriented,
Quality First
Technology Innovation,
Integrity Service
Courageous to Fight, Sincerity and Justice, Passion for Learning and Sharing, Professional and Efficient
